A PDA-DTC/Cu-MnO2 nanoplatform for MR imaging and multi-therapy for triple-negative breast cancer treatment

Xiaochun Hu1, Yonglin Lu1, Wenrong Zhao2

  • 1Breast Cancer Center, Shanghai East Hospital, School of Medicine, Shanghai Key Laboratory of Chemical Assessment and Sustainability, School of Chemical Science and Engineering, Tongji University, P. R. China. shishuo@tongji.edu.cn.

Chemical Communications (Cambridge, England)
|April 28, 2021
PubMed

Related Concept Videos